[Changes in ionized calcium and citrate levels in dogs during mechanical autotransfusion with heparin, ACD and CPD]

Chirurgisches Forum Fur Experimentelle Und Klinische Forschung
|January 1, 1979
PubMed

Insights

Autotransfusion of citrated blood in dogs caused a significant drop in ionized calcium (Ca++), especially with CPD anticoagulant. This calcium decrease, not total calcium changes, is linked to cardiac depression post-transfusion.

Area of Science:

  • Cardiovascular Physiology
  • Transfusion Medicine
  • Biochemistry

Background:

  • Autotransfusion (AT) involves reinfusing a patient's own blood.
  • Citrate-based anticoagulants are commonly used in blood preservation.
  • Cardiac function can be affected by alterations in serum calcium and citrate levels during AT.

Purpose of the Study:

  • To investigate the effects of different blood anticoagulants on serum ionized calcium (Ca++), total calcium, and citrate levels during autotransfusion in dogs.
  • To determine the relationship between these biochemical changes and cardiac depression post-AT.

Main Methods:

  • Serum samples were analyzed for Ca++, total calcium, and citrate levels in dogs undergoing AT.
  • Blood was stabilized with heparin, Acid Citrate Dextrose (ACD), or Citrate Phosphate Dextrose (CPD) anticoagulant.
  • Aortic pressure (AOP) was continuously monitored to correlate with blood sample timing.

Main Results:

  • Ionized calcium (Ca++) levels dropped significantly post-AT, with a 27% decrease with ACD and 34% with CPD.
  • Serum citrate levels increased substantially, particularly with CPD (521% increase) compared to ACD (174% increase).
  • Total serum calcium levels remained stable throughout the procedure.

Conclusions:

  • The cardiac depression observed after autotransfusion of citrated blood is primarily attributed to the significant drop in ionized calcium (Ca++).
  • CPD anticoagulant resulted in a more pronounced decrease in Ca++ and a greater increase in citrate compared to ACD.
  • These findings highlight the critical role of anticoagulant choice in managing electrolyte balance and cardiac function during autotransfusion.